The current health pandemic that has plagued the global of which the global south‐Nigeria is not insulated from is the premise for this empirical investigation. The present study relies on recent annual time‐series data to conceptualize the hypothesized claim via Pesaran's Autoregressive distributed lag techniques. Empirical findings from the bounds test traces the long‐run relationship between public health expenditure and economic growth over the study span. However, unlike previous studies, we introduce life expectancy and death rates in the model framework. Although health expenditure is not significant, empirical results show that a 1% increase in life expectancy and death rate increases and decreases economic growth by 3.85 and 1.84%, respectively. This suggests the need for Health Policymakers in Nigeria to implement active strategies that reduce the death rate, which is a blueprint for active engagement in the face of a global pandemic such as COVID‐19.

Technology is disrupting bringing up a better innovation and strengthening the healthcare services. Telehealth is one of these services. Telehealth can help in times of emergency situations as well as reducing morbidity caused by other diseases other than coronavirus and also constraining its spread as well as sustaining the country's economic development. Although, telehealth is a disruptive innovation, this article aimed to point out why Africa and rest of the world need telehealth to structure out the management of the three phases of health crises (pre, during and post-crises) that must be address to help in economic sustainability, increase accessibility to healthcare and increase in quality of life which in turn reduces costs and easy access to healthcare services either incommunicable, non-communicable, or disastrous situations in the African region. In fighting an outbreak such as this, our study finds that the government of African nations should guarantee all health experts get fitting instruction and preparing; present telehealth accreditation for wellbeing experts; give subsidizing which satisfactorily takes care of the expense of giving telehealth; overhaul clinical models of care; bolster all partners with a viable correspondence; and finally, change the board technique while setting up frameworks to oversee telehealth benefits on a standard premise.

Background and Aim: Telehealth expansion is dependent on the acceptance and satisfaction of the providers and users of the telehealth service and the impact on the overall health-care system. This study was conducted to evaluate the outcome of pharmacist-led telehealth services and satisfaction of their users. Materials and Methods: The telehealth-based drug information center service was an 8-month retrospective, descriptive study that evaluated users' service satisfaction (quality of service), general health outcomes, recommendations, and personal health outcomes by electronically distributing a questionnaire to the users using a Donabedian model approach. Results: The feedback response rate was 87.33% (N = 131). The majority of users were 25–34-year-old young adults, while regarding the background status of the enquirers (health-care worker, medical doctor, nurse, patient, phar macist, practitioner/scientist), 35 (26.7%) pharmacists and 34 (26.0%) patients were the most prevalent users. In terms of service satisfaction and health outcome, medical doctors had the highest mean ratings of 4.67 ± 0.76 and 4.95 ± 0.21, respectively. Evaluation of the pharmacist-led telehealth impact was measured with four variables, which showed a statistical significance of P < 0.001 and a highly positive mean rating generally (service satisfaction 4.44 ± 0.83, general health outcome 4.54 ± 0.85, personal health outcome 4.80 ± 0.58, and recommendation 4.85 ± 0.43). The findings also showed that user satisfaction significantly impacted on personal health outcomes (P < 0.001), and that there was an insignificant relationship between user background status and continents. Conclusions: The study reveals the significant impact of pharmacist-led telehealth services and the importance of incorporating telehealth services into drug information centers.